Center Laboratories, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Location

Taipei Taiwan - China

Primary Industry

Pharmaceuticals

Firm Ownership

Investment Team Staff

Total Staff

Request a demo to show more

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2011

684,436,000

4,407,000

0.6%

51,147,000

7.5%

9,741,000

1.4%

31 Dec 2012

713,740,000

4.3%

(40,608,000)

(5.7%)

12,002,000

1.7%

61,391,000

8.6%

31 Dec 2013

741,934,000

(39,855,000)

(5.4%)

22,357,000

67,185,000

9.1%

31 Dec 2014

898,759,000

21.1%

(69,506,000)

(7.7%)

(6,866,000)

(0.8%)

477,973,000

53.2%

31 Dec 2015

6,792,238,000

655.7%

(46,688,000)

(0.7%)

276,978,000

4.1%

435,393,000

6.4%

31 Dec 2016

15,039,831,000

121.4%

429,630,000

2.9%

1,229,745,000

8.2%

243,950,000

1.6%

31 Dec 2017

19,391,814,000

28.9%

888,037,000

4.6%

1,760,781,000

9.1%

818,766,000

4.2%

31 Dec 2018

21,648,222,000

11.6%

1,287,886,000

5.9%

2,210,878,000

10.2%

7,887,450,000

36.4%

31 Dec 2019

1,437,674,000

(93.4%)

(89,429,000)

(6.2%)

29,344,000

(203,589,000)

(14.2%)

31 Dec 2020

31 Dec 2021

31 Dec 2022

Unlock the recent years of financials and more for Center Laboratories, Inc..

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.